JB Chemicals' Enalapril Maleate Recall Signals Heightened FDA Scrutiny on Impurity Control
JB Chemicals and Pharmaceuticals Ltd initiated a Class II recall for Enalapril Maleate Tablets due to organic impurity failures, impacting 675 bottles distributed nationwide in the USA. This event, originating from Unique Pharmaceutical Laboratories in Mumbai, India, underscores critical quality control deficiencies. Procurement and regulatory teams must assess supply chain stability and identify alternative sources for this essential cardiovascular medication to mitigate disruption risks.